Invivodata
Invivodata公司对纸制病人日志的不足有着敏锐的洞察力。该公司已经支持过包括5万名病人参与的130个临床试验，是获得FDA两项审批的唯一一家电子日志公司。但是，成为众多电子日志公司的领头羊很困难，目前同类供应商众多，且都以掌上操作系统为典型产品。这家公司宣称其收入从2004年到2005年攀升了3倍。
invivodata’s scientists defined the electronic patient reported outcomes (ePRO) industry over 20 years ago. Since that time, we have focused on developing innovative ePRO solutions for clinical research that have been used in over 250 clinical trials to collect accurate patient reported outcomes (PRO) data. Our innovations included the revolutionary DiaryPRO, the electronic patient diary and SitePRO, our site-based PRO tool. With the market’s first wireless eDiary solution, automatic patient data uploads, and our development of the space-saving invivodata® EasyCharge™ connector, invivodata has evolved into the ePRO industry’s innovation-leader.

Only invivodata combines the scientific and regulatory expertise needed for ePRO with practical technology and proactive services to maximize your clinical research investment. Trial after trial, our proven ePRO systems enable sponsors to confidently determine the effectiveness of new medical products and therapies.